‘Pharma Bro’ Shkreli Loses Bid to Delay Trial Over Drug Markup

Incarcerated former pharma executive Martin Shkreli failed to delay an antitrust trial over his role in Vyera Pharmaceuticals’ 4,000% mark-up of an anti-parasitic drug, after a federal judge said the trial wouldn’t interfere with his participation in a drug rehabilitation program.

The Vyera founder’s motion to postpone the trial over antitrust claims brought by the Federal Trade Commission also was “untimely,” Judge Denis Cote said in her order Tuesday. The trial will proceed as scheduled on Dec. 14 in the U.S. District Court for the Southern District of New York, she said.

Shkreli, who is in a Pennsylvania prison, sought ...